Astrazenca has supported the CRF in the production of an informative category 1 CD about coeliac disease which can be obtained from the CRF upon request. The CD provides a valuable educational tool for GPs, health professionals and those wishing to understand the condition.
During the visit of Markku Mäki to Australia in March 2010, Astrazeneca partnered with the CRF to provide a series of seminars to gastroenterologists and experts in the field of coeliac disease.
As one of the world’s leading pharmaceutical companies, Astrazeneca focuses on discovery, knowledge and life - turning good ideas into innovative, effective medicines for important areas of healthcare.AstraZeneca Australia exports pharmaceutical products from its Sydney plant, to more than 30 countries around the world from Europe to Asia, New Zealand to Japan.